Cargando…
First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disease towards which pleiotropic approach using Multi-Target Directed Ligands is nowadays recognized as probably convenient. Among the numerous targets which are today validated against AD, acetylcholinesterase (ACh) and Monoamine Oxida...
Autores principales: | Guieu, Benjamin, Lecoutey, Cedric, Legay, Rémi, Davis, Audrey, Sopkova de Oliveira Santos, Jana, Altomare, Cosimo Damiano, Catto, Marco, Rochais, Christophe, Dallemagne, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795340/ https://www.ncbi.nlm.nih.gov/pubmed/33375412 http://dx.doi.org/10.3390/molecules26010080 |
Ejemplares similares
-
Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy
por: Lecoutey, Cédric, et al.
Publicado: (2021) -
Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer’s Disease
por: Guiselin, Thomas, et al.
Publicado: (2023) -
Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT(4) receptors activities for the treatment of Alzheimer’s disease
por: Lalut, Julien, et al.
Publicado: (2020) -
Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease
por: Toublet, François-Xavier, et al.
Publicado: (2019) -
Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif
por: Pisani, Leonardo, et al.
Publicado: (2016)